"Public Warned: Counterfeit Mounjaro Pens Linked to Health Risks"
The HPRA warns against counterfeit Mounjaro pens containing insulin instead of tirzepatide, posing severe health risks like hypoglycemia to users relying on prescription drugs for weight loss.
- The Health Products Regulatory Authority (HPRA) issued a public warning regarding counterfeit Mounjaro pens, which were sourced online and originated from outside Europe.
- Laboratory tests revealed that two of the detained pens contained insulin instead of the intended tirzepatide, heightening the risk of hypoglycemia for unsuspecting users.
- The HPRA emphasized the importance of obtaining prescription drugs only from registered pharmacies to avoid counterfeit products that could dangerously affect blood sugar levels.
Why It Matters
This event highlights the critical dangers of counterfeit medications in the market, especially for individuals using prescription drugs like tirzepatide for weight loss. Ensuring patient safety in the pharmaceutical supply chain is vital to prevent serious health risks.